The Breast Cancer Research Foundation.
October 16, 2009
H. Shelton Earp M.D. is the Director of the Lineberger Comprehensive Cancer Center and a professor of Medicine and Pharmacology at the University of North Carolina/Chapel Hill. He has spearheaded studies into Human EGF Receptor-4, HER4, which is believed to be a tumor suppressor and can be used to predict a good prognosis in breast cancer. For the full story on Dr. Earp, click here.